Pharma & Medical Lessons from TMI 31 Mar 201931 Mar 2019 Arete-Zoe: Lessons from TMI Lessons from big industrial accidents and their relevance for the Pharma industry.https://player.slideplayer.com/33/10154272/
Pharma & Medical Essential Medicines in Hungary 31 Mar 2019 Availability of Essential Medicines in Hungary shows summary tables that compare the World Health Organization Essential Medicines List (WHO EML) with the National Substitution List (NL) by system organ class.…
Pharma & Medical Rethinking post-market drug safety surveillance 3 Dec 201731 Mar 2019 Pharmacovigilance information collected through post-authorization surveillance systems is used to change drug labeling and update benefit:risk profile of marketed drugs. Physicians make clinical decisions based on this information. Accurate assessment…
Pharma & Medical Modern Oncology Therapies 14 Nov 2017 Review of novel biological cancer therapies and exploration of ways that would make them locally available within the context of a low-to-middle income EU country. doi: 10.13140/RG.2.2.22894.72002
Pharma & Medical CYP2D6 and CYP3A4 in opioid metabolism: Time to develop guidance for PGX biomarkers? 20 Oct 201720 Oct 2017 Clinically relevant insight into genetic makeup and phenotypic biomarkers, such as ADMET and treatment outcomes, would significantly improve predictability of individual response to medications. The combination of metabolomic and pharmacogenomic…
Pharma & Medical The business case for more robust pre-clinical research 20 Oct 201720 Oct 2017 In the high consequence environment of pharmaceutical development, any assumption made earlier in the process can prove extremely costly if uncorrected once more information becomes available. From a business perspective,…
